• metavia reports additional positive top-line results from the mad part 2 of its phase 1 study of da-1726, a novel 31 ratio glp-1 a... marketscreener.com Tue, 22 Apr 2025 12:33:08 GMT
• metavia’s (mtva) buy rating reiterated at hc wainwright Defense World Sat, 19 Apr 2025 07:00:00 GMT
• MetaVia’s obesity drug cuts body weight by 6.3% in 26 days in phase 1 koreabiomed.com Wed, 16 Apr 2025 07:00:00 GMT
• Metavia Announces Positive Top-Line Data From The 4-Week Phase 1 Mad Trial Of Da-1726 marketscreener.com Tue, 15 Apr 2025 07:00:00 GMT
• metavia reports 'positive' results for obesity treatment in part 2 of phase 1 trial marketscreener.com Tue, 15 Apr 2025 07:00:00 GMT
• metavia inc. reports progress in cardiometabolic drug development MSN Mon, 24 Mar 2025 23:44:06 GMT
• fy2029 earnings forecast for metavia issued by hc wainwright Defense World Mon, 24 Mar 2025 07:00:00 GMT
• hc wainwright reaffirms “buy” rating for metavia (nasdaq:mtva) Defense World Sun, 23 Mar 2025 07:00:00 GMT
• metavia inc. reports progress in cardiometabolic drug development MSN Sat, 22 Mar 2025 19:06:20 GMT
• metavia inc (mtva) reports q4 eps of -0.59, revenue at $0 millio GuruFocus Sat, 22 Mar 2025 08:35:26 GMT
• metavia inc. reports progress in cardiometabolic drug development TipRanks Fri, 21 Mar 2025 07:00:00 GMT
• MetaVia Reports Year End 2024 Financial Results and Provides Corporate Update PR Newswire Thu, 20 Mar 2025 07:00:00 GMT
• metavia (mtva) expected to announce quarterly earnings on thursday Defense World Thu, 20 Mar 2025 07:00:00 GMT
• neurobo pharmaceuticals (nrbo) to release quarterly earnings on thursday Defense World Thu, 20 Mar 2025 07:00:00 GMT
• neurobo says da-1241, wegovy combo shows potential in treating mash MSN Wed, 19 Mar 2025 12:36:25 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) stock price up 1.5% – still a buy? Defense World Tue, 18 Feb 2025 08:00:00 GMT
• financial survey: neurobo pharmaceuticals (nasdaq:nrbo) & northwest biotherapeutics (otcmkts:nwbo) Defense World Wed, 29 Jan 2025 08:00:00 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) stock price up 2.9% – here’s why Defense World Wed, 22 Jan 2025 08:00:00 GMT
• neurobo pharmaceuticals : statement of changes in beneficial ownership - form 4 Marketscreener.com Tue, 14 Jan 2025 03:16:10 GMT
• non-alcoholic steatohepatitis market to show remarkable growth trends from 2024 to 2034, delveinsight reports | madrigal pharmac, ... The Globe and Mail Wed, 08 Jan 2025 22:28:25 GMT
• what is hc wainwright’s estimate for metavia q4 earnings? Defense World Thu, 02 Jan 2025 08:00:00 GMT
• analysts offer predictions for metavia fy2024 earnings Defense World Wed, 01 Jan 2025 08:00:00 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) trading down 2.8% – what’s next? Defense World Tue, 31 Dec 2024 08:00:00 GMT
• metavia (nasdaq:mtva) now covered by analysts at hc wainwright Defense World Tue, 31 Dec 2024 08:00:00 GMT
• metavia shares debut with buy rating as da-1726 shows preclinical weight-loss results Investing.com Mon, 30 Dec 2024 08:00:00 GMT
• mtva stock touches 52-week low at $2 amid market challenges Investing.com Australia Thu, 19 Dec 2024 01:21:08 GMT
• MetaVia reports positive DA-1241 trial results for MASH Investing.com Wed, 18 Dec 2024 08:00:00 GMT
• mtva stock touches 52-week low at $2 amid market challenges Investing.com Wed, 18 Dec 2024 08:00:00 GMT
• neurobo pharmaceuticals : reports third quarter 2021 financial results - form 8-k Marketscreener.com Tue, 17 Dec 2024 15:50:23 GMT
• reviewing intercure (nasdaq:incr) & neurobo pharmaceuticals (nasdaq:nrbo) Defense World Sun, 15 Dec 2024 08:00:00 GMT
• diabetic nephropathy market expected to experience major growth by 2034, according to delveinsight | astrazeneca, neurobo pharma, ... Barchart Tue, 10 Dec 2024 08:00:00 GMT
• mtva stock touches 52-week low at $2.04 amid market challenges Investing.com India Sat, 07 Dec 2024 01:53:17 GMT
• mtva stock touches 52-week low at $2.04 amid market challenges Investing.com Fri, 06 Dec 2024 08:00:00 GMT
• neurobo pharmaceuticals, inc. announced that it expects to receive $10 million in funding Marketscreener.com Wed, 04 Dec 2024 13:08:14 GMT
• neurobo pharmaceuticals, inc. announced that it expects to receive $15 million in funding from dong-a st co., ltd. Marketscreener.com Mon, 02 Dec 2024 17:26:47 GMT
• neurobo pharmaceuticals, inc. appoints d. gordon strickland to its board of directors Marketscreener.com Sat, 30 Nov 2024 08:52:48 GMT
• neurobo pharmaceuticals, inc. announces unaudited consolidated earnings results for the first quarter ended march 31, 2021 Marketscreener.com Sat, 30 Nov 2024 07:15:05 GMT
• neurobo pharmaceuticals appoints hyung heon kim as chief executive officer and president Marketscreener.com Sat, 30 Nov 2024 07:11:00 GMT
• neurobo pharmaceuticals, inc. completes enrollment of part 1 of its phase 2a clinical trial evaluating da-1241 for the treatment o... Marketscreener.com Sat, 30 Nov 2024 06:54:21 GMT
• neurobo to participate in the h.c. wainwright 26th annual global investment conference Marketscreener.com Sat, 30 Nov 2024 06:26:01 GMT
• neurobo pharmaceuticals announces executive changes Marketscreener.com Sat, 30 Nov 2024 06:23:31 GMT
• neurobo pharmaceuticals, inc. decides to discontinue its clinical development of ana001 (niclosamide) and clinical development of ... Marketscreener.com Sat, 30 Nov 2024 06:22:49 GMT
• neurobo pharmaceuticals, inc. receives first site irb approval for its phase 2a clinical trial evaluating da-1241 for the treatmen... Marketscreener.com Sat, 30 Nov 2024 06:20:49 GMT
• neurobo pharmaceuticals, inc. announces management changes Marketscreener.com Sat, 30 Nov 2024 06:19:13 GMT
• neurobo pharmaceuticals, inc. announces ceo changes Marketscreener.com Sat, 30 Nov 2024 06:17:35 GMT
• neurobo pharmaceuticals, inc. announces the appointment of current board member, hyung heon ("h.h.") kim as the company's presiden... Marketscreener.com Sat, 30 Nov 2024 06:08:30 GMT
• neurobo pharmaceuticals, inc. announces board changes Marketscreener.com Sat, 30 Nov 2024 06:00:58 GMT
• neurobo pharmaceuticals announces management changes Marketscreener.com Sat, 30 Nov 2024 05:59:33 GMT
• neurobo pharmaceuticals, inc. announces exclusive license agreement with mthera pharma co., ltd. for nb-01 Marketscreener.com Sat, 30 Nov 2024 05:54:29 GMT
• neurobo pharmaceuticals, inc. elects hyung heon kim and andrew i. koven to board of directors Marketscreener.com Sat, 30 Nov 2024 05:50:18 GMT
• neurobo pharmaceuticals, inc. announces executive changes Marketscreener.com Sat, 30 Nov 2024 05:47:44 GMT
• neurobo pharmaceuticals, inc. announces joint research agreement, together with dong-a st and immunoforge to develop a long-acting... Marketscreener.com Sat, 30 Nov 2024 05:46:57 GMT
• neurobo pharmaceuticals, inc. reports earnings results for the third quarter and nine months ended september 30, 2024 Marketscreener.com Sat, 30 Nov 2024 05:39:09 GMT
• neurobo pharmaceuticals reveals promising therapeutic developments TipRanks Fri, 29 Nov 2024 08:00:00 GMT
• neurobo pharmaceuticals announces strategic realignment ahead of important clinical milestones with name change to metavia - refle... Yahoo Finance Mon, 18 Nov 2024 08:00:00 GMT
• neurobo pharma rebrands as metavia, advances $70m cardiometabolic pipeline StockTitan Mon, 18 Nov 2024 08:00:00 GMT
• neurobo rebrands to metavia, changes nasdaq ticker to mtva Investing.com Mon, 18 Nov 2024 08:00:00 GMT
• armistice capital, llc acquires shares in neurobo pharmaceuticals inc GuruFocus.com Fri, 15 Nov 2024 04:47:59 GMT
• neurobo pharmaceuticals to participate in investor conferences in november cnhinews.com Wed, 13 Nov 2024 08:00:00 GMT
• nrbo: topline results for phase 2a trial of da-1241 in mash expected in december 2024 Yahoo Finance Wed, 13 Nov 2024 08:00:00 GMT
• neurobo pharmaceuticals to present at the november 21st virtual investor summit microcap event Financial Content Mon, 11 Nov 2024 08:00:00 GMT
• neurobo pharmaceuticals reports third quarter 2024 financial results and provides corporate update citybiz Thu, 07 Nov 2024 19:32:47 GMT
• neurobo pharmaceuticals completes final dosing in us phase 2 trial for mash treatment KBR Tue, 05 Nov 2024 08:00:00 GMT
• neurobo pharmaceuticals completes phase 2a trial for mash drug TipRanks Mon, 04 Nov 2024 08:00:00 GMT
• diabetic nephropathy market to reach new heights in growth by 2034, delveinsight predicts | astrazeneca, neurobo pharma, don-a st,... Barchart Tue, 22 Oct 2024 07:00:00 GMT
• nrbo stock touches 52-week low at $2.55 amid market challenges Investing.com Thu, 10 Oct 2024 07:00:00 GMT
• neurobo pharmaceuticals unveils updated corporate presentation TipRanks Mon, 07 Oct 2024 11:32:29 GMT
• neurobo confirms safety of obesity drug da-1726 in phase 1 study KBR Fri, 04 Oct 2024 07:00:00 GMT
• here's why we're a bit worried about neurobo pharmaceuticals' (nasdaq:nrbo) cash burn situation Simply Wall St Thu, 03 Oct 2024 07:00:00 GMT
• nrbo stock touches 52-week low at $2.9 amid market challenges by investing.com Investing.com South Africa Wed, 02 Oct 2024 03:39:28 GMT
• NRBO: Positive SAD Part 1 Data; MAD Part 2 Results Expected in 1Q25… Zacks Small Cap Research Tue, 01 Oct 2024 07:00:00 GMT
• nrbo - neurobo pharmaceuticals inc latest stock news & market updates Stock Titan Tue, 01 Oct 2024 07:00:00 GMT
• neurobo pharmaceuticals to participate in investor conferences in october Finansavisen Tue, 01 Oct 2024 07:00:00 GMT
• nrbo stock touches 52-week low at $2.9 amid market challenges Investing.com India Tue, 01 Oct 2024 07:00:00 GMT
• neurobo reports positive early trial results for obesity drug by investing.com Investing.com South Africa Tue, 01 Oct 2024 03:00:10 GMT
• neurobo pharmaceuticals announces data from sad part 1 of trial of da-1726 TipRanks Mon, 30 Sep 2024 12:30:41 GMT
• nrbo: positive sad part 1 data; mad part 2 results expected in 1q25… MSN Mon, 30 Sep 2024 07:00:00 GMT
• we're a little worried about neurobo pharmaceuticals' (nasdaq:nrbo) cash burn rate Yahoo Finance Mon, 30 Sep 2024 07:00:00 GMT
• neurobo reports positive early trial results for obesity drug by investing.com Investing.com Australia Mon, 30 Sep 2024 07:00:00 GMT
• affinity asset advisors llc invests $432,000 in neurobo pharmaceuticals, inc. (nasdaq:nrbo) Defense World Wed, 25 Sep 2024 13:21:04 GMT
• neurobo shareholders approve significant stock issuance Investing.com India Fri, 20 Sep 2024 12:21:21 GMT
• dong-a st executives sell neurobo pharmaceuticals shares worth over $1,500 Investing.com Fri, 20 Sep 2024 07:00:00 GMT
• neurobo to participate in the h.c. wainwright 26th annual global investment conference Finansavisen Tue, 03 Sep 2024 07:00:00 GMT
• nrbo: data from part 1 of phase 1 trial of da-1726 in 3q24… Yahoo Finance Wed, 21 Aug 2024 07:00:00 GMT
• neurobo pharmaceuticals completes patient enrollment for phase 1 trial for antiobesity drug The Korea Herald Fri, 16 Aug 2024 07:00:00 GMT
• neurobo pharmaceuticals inc. filed sec form 8-k: results of operations and financial condition, financial statements and exhibits Quantisnow Wed, 14 Aug 2024 12:01:18 GMT
• neurobo concludes subject enrolment in sad portion of obesity treatment trial Clinical Trials Arena Wed, 14 Aug 2024 07:00:00 GMT
• neurobo pharmaceuticals reports second quarter 2024 financial results and provides corporate update The Eastern Progress Online Wed, 14 Aug 2024 07:00:00 GMT
• neurobo pharmaceuticals reports q2 eps ($1.85), consensus ($1.12) TipRanks Wed, 14 Aug 2024 07:00:00 GMT
• neurobo pharmaceuticals completes enrollment of the sad part 1 of its phase 1 clinical trial evaluating da-1726 for the treatment ... Finansavisen Tue, 13 Aug 2024 07:00:00 GMT
• neurobo completes first phase 1 enrollment for obesity drug trial TipRanks Tue, 13 Aug 2024 07:00:00 GMT
• neurobo pharmaceuticals completes enrollment in phase 1 trial of da-1726 TipRanks Tue, 13 Aug 2024 07:00:00 GMT
• dong-a st and its subsidiary to codevelop long-acting obesity drug with immunoforge KBR Thu, 08 Aug 2024 07:00:00 GMT
• obesity clinical trial pipeline appears robust with 80+ key pharma companies actively working in the therapeutics segment | delvei... India Shorts Tue, 06 Aug 2024 16:30:00 GMT
• neurobo pharmaceuticals signs research agreement for obesity treatment TipRanks Tue, 06 Aug 2024 12:00:00 GMT
• neurobo pharmaceuticals announces joint research agreement, together with dong-a st and immunoforge to develop a long-acting once-... Finansavisen Tue, 06 Aug 2024 07:00:00 GMT
• neurobo partners for long-acting obesity treatment Investing.com India Tue, 06 Aug 2024 07:00:00 GMT
• neurobo partners for monthly dual-action diabetes drug development TipRanks Tue, 06 Aug 2024 07:00:00 GMT
• NeuroBo licenses NB-01 to MThera Pharma for diabetic neuropathy treatment koreabiomed.com Wed, 31 Jul 2024 07:00:00 GMT
• NeuroBo Signs Exclusive License Agreement with MTHERA for NB-01 Contract Pharma Tue, 30 Jul 2024 07:00:00 GMT
• neurobo licenses diabetic neuropathy drug to mthera pharma Investing.com Tue, 30 Jul 2024 07:00:00 GMT
• neurobo pharmaceuticals announces license agreement with mthera pharma TipRanks Tue, 30 Jul 2024 07:00:00 GMT
• dong-a st’s q2 operating profit falls 19% on year due to smaller prescription drugs sales KBR Fri, 26 Jul 2024 07:00:00 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) shares down 3.4% Defense World Wed, 17 Jul 2024 07:00:00 GMT
• bix 2024: from graveyard to breakthrough, mash candidates on rise BioWorld Online Tue, 16 Jul 2024 16:00:00 GMT
• neurobo pharmaceuticals doses first patient in mad part 2 of da-1726 trial TipRanks Tue, 16 Jul 2024 15:17:39 GMT
• donga st, subsidiary mash and obesity drug clinical results expected this year 코메디닷컴 Tue, 16 Jul 2024 07:00:00 GMT
• neurobo pharmaceuticals releases corporate presentation update TipRanks Tue, 16 Jul 2024 07:00:00 GMT
• bix 2024: from graveyard to breakthrough, mash candidates on rise BioWorld Online Thu, 11 Jul 2024 07:00:00 GMT
• hanmi pharm, neurobo unveil next-gen obesity drugs at bioplus-interphex korea 2024 KBR Thu, 11 Jul 2024 07:00:00 GMT
• neurobo pharmaceuticals to present at the emerging growth conference in july Finansavisen Thu, 11 Jul 2024 07:00:00 GMT
• amendment: large owner dong-a st co., ltd bought $10,000,003 worth of shares (2,544,530 units at $3.93), increasing direct ownersh... Quantisnow Wed, 10 Jul 2024 15:17:10 GMT
• [top trends] homozygous familial hypercholesterolemia epidemiology market | neurobo pharmaceuticals, aegerion pharmaceutical, arro... Economica Mon, 08 Jul 2024 09:23:07 GMT
• nrbo: da-1726 shows superiority to survodutide in pre-clinical models… Yahoo Finance Mon, 01 Jul 2024 07:00:00 GMT
• huge insider buying at a warren buffett pick and 5 other stocks 24/7 Wall St. Sun, 30 Jun 2024 07:00:00 GMT
• r&d focus sets dong-a st apart in biosimilars The Korea JoongAng Daily Fri, 28 Jun 2024 07:00:00 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) versus jazz pharmaceuticals (nasdaq:jazz) financial contrast Defense World Fri, 28 Jun 2024 07:00:00 GMT
• neurobo pharmaceuticals, inc. appoints pharmaceutical industry executive, mark a. glickman, to its board of directors The Globe and Mail Thu, 27 Jun 2024 11:49:11 GMT
• NeuroBo doses first subject in Part 2 of Phase I obesity treatment trial Clinical Trials Arena Thu, 27 Jun 2024 07:00:00 GMT
• neurobo begins dosing patients for obesity drug’s us phase 1 trial KBR Thu, 27 Jun 2024 07:00:00 GMT
• neurobo starts obesity drug trial ahead of schedule Investing.com India Thu, 27 Jun 2024 07:00:00 GMT
• neurobo pharmaceuticals, inc. (nasdaq:nrbo) major shareholder st co. ltd dong-a acquires 2544530 shares Defense World Thu, 27 Jun 2024 05:04:32 GMT
• evaxion biotech advances in personalized cancer vaccine by investing.com Investing.com India Wed, 26 Jun 2024 19:11:06 GMT
• chipotle shares maintain buy rating, price target adjusted on recent stock split by investing.com Investing.com India Wed, 26 Jun 2024 18:53:13 GMT
• chipotle shares start trading post 50-for-1 stock split by investing.com Investing.com India Wed, 26 Jun 2024 18:53:12 GMT
• draftkings stock target cut, maintains buy rating by investing.com Investing.com Wed, 26 Jun 2024 18:43:55 GMT
• neurobo pharmaceuticals inc. filed sec form 8-k: other events, financial statements and exhibits Quantisnow Wed, 26 Jun 2024 13:20:25 GMT
• earnings call: fedex reports strong q4 with focus on efficiency and growth by investing.com Investing.com UK Wed, 26 Jun 2024 12:48:00 GMT
• continued pre-market rally for neurobo (nrbo) stock Stocks Telegraph Wed, 26 Jun 2024 09:58:00 GMT
• neurobo pharmaceuticals and 2 other penny stocks insiders are buying Benzinga Wed, 26 Jun 2024 07:00:00 GMT
• neurobo pharmaceuticals doses first patient in the mad part 2 of its phase 1 clinical trial evaluating da-1726 for the treatment o... Finansavisen Wed, 26 Jun 2024 07:00:00 GMT
• neurobo, yet another glp-1 company, sells shares for $70 million The Pharma Letter Wed, 26 Jun 2024 07:00:00 GMT
• neurobo pharmaceuticals doses first patient in mad part 2 of da-1726 trial TipRanks Wed, 26 Jun 2024 07:00:00 GMT
• kintara therapeutics restructures share designations by investing.com Investing.com Wed, 26 Jun 2024 07:00:00 GMT
• aerwins technologies announces board member resignation by investing.com Investing.com Wed, 26 Jun 2024 07:00:00 GMT
• cathie wood's ark etf focuses on pagerduty, 10x genomics stock by investing.com Investing.com Wed, 26 Jun 2024 00:38:03 GMT
• dong-a st co. acquires $7.96m of neurobo pharmaceuticals shares by investing.com Investing.com Wed, 26 Jun 2024 00:38:03 GMT
• pool corp stock target cut, outperform rating on lower revenue outlook by investing.com Investing.com Australia Tue, 25 Jun 2024 20:23:22 GMT
• td cowen maintains buy on humacyte with $7.50 target by investing.com Investing.com Canada Tue, 25 Jun 2024 20:22:38 GMT
• rigel pharmaceuticals to execute 1-for-10 reverse stock split by investing.com Investing.com Australia Tue, 25 Jun 2024 20:22:09 GMT
• revolutionizing obesity treatment: neurobo’s innovative approach Bit Perfect Solutions Tue, 25 Jun 2024 07:00:00 GMT
• neurobo pharmaceuticals announces the closing of up to $70 million concurrent private placement and registered direct offering pri... Finansavisen Tue, 25 Jun 2024 07:00:00 GMT
• dong-a st co. acquires $7.96m of neurobo pharmaceuticals shares Investing.com Tue, 25 Jun 2024 07:00:00 GMT
• jll launches $2.5 billion commercial paper program by investing.com Investing.com Canada Tue, 25 Jun 2024 07:00:00 GMT
• neurobo secures $20 million in private placement Investing.com India Mon, 24 Jun 2024 22:09:02 GMT
• expensify exec steven mclaughlin buys $128.8k in shares by investing.com Investing.com Mon, 24 Jun 2024 19:49:32 GMT
• neurobo secures $20 million in private placement by investing.com Investing.com Mon, 24 Jun 2024 19:49:32 GMT
• neurobo pharmaceuticals’ da-1726 demonstrates ‘superiority in weight loss’ TipRanks Mon, 24 Jun 2024 10:58:10 GMT
• neurobo pharmaceuticals' da-1726 demonstrates 'superiority in weight loss' - tipranks.com TipRanks Mon, 24 Jun 2024 10:58:10 GMT
• neurobo pharmaceuticals to sell 4.33m shares at $3.93 in private placement TipRanks Mon, 24 Jun 2024 07:00:00 GMT
• neurobo pharmaceuticals shares rise on positive results for weight-loss drug MarketWatch Mon, 24 Jun 2024 07:00:00 GMT
• some pharma companies with promising glp-1 trials could do quite well next year: portfolio manager BNN Bloomberg Sun, 23 Jun 2024 13:18:38 GMT
• NeuroBo Pharmaceuticals' DA-1726 Demonstrated Superiority in Weight Loss, Retention of Lean Body Mass, and Lipid-Lowering Effects ... PR Newswire Sat, 22 Jun 2024 07:00:00 GMT
• intra-cellular stock price target lifted on caplyta optimism by investing.com Investing.com Thu, 20 Jun 2024 07:00:00 GMT
• marsh & mclennan director oscar fanjul sells over $1.25m in stock by investing.com Investing.com Mon, 17 Jun 2024 07:00:00 GMT
• diabetic neuropathic pain pipeline and clinical trials assessment 2024: fda approvals, therapies and key ... openPR Thu, 13 Jun 2024 13:50:00 GMT
• funko shares target raised by b.riley on new ceo strategy by investing.com Investing.com UK Mon, 10 Jun 2024 07:00:00 GMT
• enliven therapeutics coo sells over $22k in company stock by investing.com Investing.com Mon, 10 Jun 2024 07:00:00 GMT
• neurobo pharmaceuticals enhances equity plan and elects directors - tipranks.com TipRanks Fri, 07 Jun 2024 21:19:05 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) is in a good position to deliver on growth plans Yahoo Sport Australia Tue, 04 Jun 2024 07:18:33 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) is in a good position to deliver on growth plans Yahoo Sport Australia Mon, 03 Jun 2024 20:18:33 GMT
• no hormones, no problem: yourchoice's first-of-its-kind male birth control is safe for men, so far Fierce Biotech Mon, 03 Jun 2024 07:00:00 GMT
• neurobo pharmaceuticals (nrbo) surges: stock moves 5.2% higher Yahoo Canada Shine On Fri, 31 May 2024 00:02:02 GMT
• neurobo pharmaceuticals, inc. (nasdaq:nrbo) to post q2 2024 earnings of ($1.38) per share, zacks small cap ... Defense World Thu, 30 May 2024 07:00:00 GMT
• the emerging role of glucagon-like peptide-1 receptor agonists for the treatment of metabolic dysfunction-associated steatohepatit... Healio Wed, 29 May 2024 17:34:44 GMT
• nrbo: preclinical data on da-1241 with semaglutide to be presented at easl congress 2024 Zacks Small Cap Research Tue, 28 May 2024 07:00:00 GMT
• jpmorgan cuts keysight shares target on margin concerns by investing.com Investing.com Tue, 28 May 2024 07:00:00 GMT
• trading day triumph: neurobo pharmaceuticals inc (nrbo) ends at 4.13, a 3.90 surge/plunge – dwinnex The Dwinnex Mon, 27 May 2024 07:00:00 GMT
• neurobo to report pre-clinical data on da-1241 at easl congress 2024 - tipranks.com TipRanks Fri, 24 May 2024 09:26:00 GMT
• dong-a st and neurobo pharmaceuticals to present data on mash treatment candidate at eu meet KBR Fri, 24 May 2024 07:00:00 GMT
• neurobo pharmaceuticals inc (nrbo) stock: a year of highs and lows The InvestChronicle Thu, 23 May 2024 14:11:57 GMT
• neurobo reports liver fibrosis treatment progress by investing.com Investing.com UK Wed, 22 May 2024 17:40:00 GMT
• neurobo says da-1241, wegovy combo shows potential in treating mash (nasdaq:nrbo) Seeking Alpha Wed, 22 May 2024 14:01:06 GMT
• NeuroBo Pharmaceuticals' DA-1241 in Combination with Semaglutide Improves Liver Fibrosis and Demonstrates Additive Hepatoprotectiv... PR Newswire Wed, 22 May 2024 07:00:00 GMT
• neurobo pharmaceuticals stock slides despite animal study showing wegvoy, liver fibrosis success - neurob Benzinga Wed, 22 May 2024 07:00:00 GMT
• neurobo pharmaceuticals reports q1 eps ($1.32) vs (51c) last year - tipranks.com TipRanks Sat, 11 May 2024 11:50:14 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) coverage initiated at maxim group Defense World Fri, 10 May 2024 05:49:55 GMT
• neurobo pharmaceuticals reports first quarter 2024 financial results and provides corporate update citybiz Thu, 09 May 2024 20:04:43 GMT
• nrbo stock earnings: neurobo pharmaceuticals misses eps for q1 2024 MSN Thu, 09 May 2024 18:09:56 GMT
• maxim group sets buy rating on neurobo stock, cites potential Investing.com Wed, 08 May 2024 07:00:00 GMT
• neurobo reports progress in cardiometabolic drug trials Investing.com India Tue, 30 Apr 2024 22:41:15 GMT
• kintara therapeutics restructures share designations by investing.com Investing.com India Tue, 30 Apr 2024 07:00:00 GMT
• neurobo pharmaceuticals' shareholders elect hyung heon kim and andrew i. koven to neurobo's board of directors Quantisnow Sun, 28 Apr 2024 23:06:57 GMT
• neurobo pharmaceuticals, inc. (nasdaq:nrbo) short interest update Defense World Sun, 28 Apr 2024 05:51:16 GMT
• fy2024 eps estimates for neurobo pharmaceuticals, inc. reduced by analyst (nasdaq:nrbo) Defense World Sat, 27 Apr 2024 10:29:39 GMT
• neurobo pharmaceuticals, inc. forecasted to earn q1 2024 earnings of ($0.95) per share (nasdaq:nrbo) Defense World Fri, 26 Apr 2024 05:37:07 GMT
• booking holdings revises by-laws amid regulatory updates by investing.com Investing.com Mon, 22 Apr 2024 07:00:00 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) versus ainos (nasdaq:aimd) critical contrast Defense World Fri, 19 Apr 2024 06:23:13 GMT
• neurobo pharmaceuticals doses first patient in its phase 1 clinical trial evaluating da-1726 for the treatment of ... Investing.com India Wed, 17 Apr 2024 07:00:00 GMT
• neurobo pharmaceuticals doses first patient in phase 1 da-1726 trial - tipranks.com TipRanks Wed, 17 Apr 2024 07:00:00 GMT
• neurobo receives approval to progress phase iia mash treatment trial GlobalData Thu, 04 Apr 2024 07:01:51 GMT
• neurobo pharmaceuticals (nasdaq:nrbo) trading down 3.2% Defense World Wed, 03 Apr 2024 07:00:00 GMT
• neurobo pharmaceuticals, a subsidiary of dong-a st, announced on the 2nd that it has completed the r.. - mk 매일경제 Tue, 02 Apr 2024 08:18:22 GMT
• neurobo completes enrollment for mash drug trial by investing.com Investing.com Mon, 01 Apr 2024 18:44:51 GMT
• neurobo pharmaceuticals completes enrollment of part 1 of its phase 2a clinical trial evaluating da-1241 for the ... Lelezard Mon, 01 Apr 2024 12:39:48 GMT
• neurobo completes enrollment for mash drug trial Investing.com India Mon, 01 Apr 2024 07:00:00 GMT
• neurobo pharmaceuticals inc reports results for the quarter ended in december - earnings summary TradingView Thu, 28 Mar 2024 21:02:37 GMT
• neurobo pharmaceuticals reports year end 2023 financial results and provides corporate update Longview News-Journal Thu, 28 Mar 2024 07:00:00 GMT
• neurobo pharmaceuticals inc expected to post a loss of 78 cents a share - earnings preview XM Tue, 26 Mar 2024 20:15:08 GMT
• prism marketview spotlights companies leading the charge in liver disease treatment following landmark fda ... Yahoo Finance Mon, 18 Mar 2024 07:00:00 GMT
• homozygous familial hypercholesterolemia epidemiology market growth drivers | neurobo pharmaceuticals ... Amoré Fri, 15 Mar 2024 19:18:51 GMT
• neurobo receives approval to progress phase iia mash treatment trial Clinical Trials Arena Thu, 14 Mar 2024 07:00:00 GMT
• neurobo receives approval to progress mash treatment trial Clinical Trials Arena Thu, 14 Mar 2024 07:00:00 GMT
• neurobo phase 2a study for mash drug to proceed as planned (nasdaq:nrbo) Seeking Alpha Wed, 13 Mar 2024 15:06:04 GMT
• neurobo pharma rises after safety review says mash drug study can continue XM Wed, 13 Mar 2024 12:40:54 GMT
• neurobo pharmaceuticals cleared to continue phase 2a trial of da-1241 - tipranks.com TipRanks Wed, 13 Mar 2024 12:00:00 GMT
• neurobo's phase 2a trial of da-124 proceeds after safety review by investing.com Investing.com South Africa Wed, 13 Mar 2024 07:00:00 GMT
• will neurobo pharmaceuticals inc (nrbo) stay at the top of the healthcare sector? InvestorsObserver Wed, 06 Mar 2024 08:00:00 GMT
• neurobo pharmaceuticals elevates marshall woodworth to cfo, aiming to strengthen cardiometabolic disease fight BNN Breaking Mon, 04 Mar 2024 14:08:33 GMT
• neurobo pharmaceuticals appoints marshall woodworth as cfo (nasdaq:nrbo) Seeking Alpha Mon, 04 Mar 2024 13:05:45 GMT
• neurobo pharmaceuticals announces key leadership appointment - tipranks.com TipRanks Mon, 04 Mar 2024 12:44:17 GMT
• neurobo names marshall woodworth as permanent cfo by investing.com Investing.com Mon, 04 Mar 2024 08:00:00 GMT
NeuroBo Pharmaceuticals, Inc.(NASDAQ:NRBO) 
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for coronavirus, neurodegenerative, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which has completed Phase 2 clinical trial to treat patients with mode...
Website: http://www.neurobopharma.com
Founded: 2017
CEO: Richard Kang
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends